We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

Supplier sentenced for illegal sales of non-approved drugs
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

According to the U.S. Department of Justice, a federal court in Virginia has sentenced a U.S. citizen, who owned and operated several companies in


Human Longevity to sequence genes of 40,000 individuals
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

According to a news source, J. Craig Venter and two others recently launched Human Longevity after raising an initial $70 million from private


Business startups in 30-year decline
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

According to data compiled by the Brookings Institution and Kansas City's Kauffman Foundation, business startups have been in a steady decline during


Biotech with hyperkalemia treatment files for $86-million IPO
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

ZS Pharma has reportedly filed a registration statement with the U.S. Securities and Exchange Commission indicating its intent to raise up to $86


Genetic screening company secures $28 million to expand product line and market tests
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

A Silicon Valley startup company that focuses on screening prospective parents for more than 100 rare inherited diseases has reportedly raised $28


Patent reforms targeting abusive litigation remain stalled in Senate
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

A coalition of companies, trade associations and startups concerned about delays in the U.S. Senate in enacting patent law reforms to address


News bytes - 24 January 2013
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2013

The U.S. Patent and Trademark Office (USPTO) publishes its final rule setting or adjusting patent fees under the Leahy-Smith America Invents Act


Patent trial awards soared in 2012, many reversed on appeal
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2013

While some verdicts in patent infringement lawsuits in recent years have exceeded $1 billion, and at least seven topped $100 million in 2012, the


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

The U.S. Food and Drug Administration (FDA) issues a final rule amending its "postmarketing safety reporting regulations for human drug and


Drug patent-protection incentives needed?
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2014

Noting that several members of Congress recently demanded that a pharmaceutical company justify the high cost of its hepatitis C drug, the